Solute Carrier Family 45, Member 2 (SLC45A2) Peptide
SLC45A2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939366
Quick Overview for Solute Carrier Family 45, Member 2 (SLC45A2) Peptide (ABIN939366)
Target
SLC45A2
(Solute Carrier Family 45, Member 2 (SLC45A2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- IGWTAFLSNM LFFTDFMGQI VYRGDPYSAH NSTEFLIYER GVEVGCWGFC
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC45 A2 antibody,
Alternative Names: SLC45A2 control peptide, SLC45A2 antibody Blocking Peptide, Anti-SLC45A2 Blocking Peptide, Solute Carrier Family 45 Member 2 Blocking Peptide, 1A1 Blocking Peptide, AIM1 Blocking Peptide, MATP Blocking Peptide, SLC45A2, SLCA2-45, SLCA2 45, SLCA2-45 Blocking Peptide, SLCA2 45 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- SLC45A2 (Solute Carrier Family 45, Member 2 (SLC45A2))
-
Background
- SLC45A2 is a melanocyte differentiation antigen that is expressed in a high percentage of melanoma cell lines. A similar sequence gene in medaka, 'B,' encodes a transporter that mediates melanin synthesis. Mutations in this gene are a cause of oculocutaneous albinism type 4.
-
Molecular Weight
- 51 kDa
Target
-
You are here:
